These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 28277487)

  • 1. Randomized Controlled Trial of an Intervention to Maintain Suppression of HIV Viremia After Prison Release: The imPACT Trial.
    Wohl DA; Golin CE; Knight K; Gould M; Carda-Auten J; Groves JS; Napravnik S; Cole SR; White BL; Fogel C; Rosen DL; Mugavaro MJ; Pence BW; Flynn PM
    J Acquir Immune Defic Syndr; 2017 May; 75(1):81-90. PubMed ID: 28277487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral Adherence Following Prison Release in a Randomized Trial of the imPACT Intervention to Maintain Suppression of HIV Viremia.
    DiPrete BL; Pence BW; Golin CE; Knight K; Flynn PM; Carda-Auten J; Groves JS; Powers KA; White BL; Napravnik S; Wohl DA
    AIDS Behav; 2019 Sep; 23(9):2386-2395. PubMed ID: 30963321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive case management before and after prison release is no more effective than comprehensive pre-release discharge planning in linking HIV-infected prisoners to care: a randomized trial.
    Wohl DA; Scheyett A; Golin CE; White B; Matuszewski J; Bowling M; Smith P; Duffin F; Rosen D; Kaplan A; Earp J
    AIDS Behav; 2011 Feb; 15(2):356-64. PubMed ID: 21042930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
    Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
    JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individuals motivated to participate in adherence, care and treatment (imPACT): development of a multi-component intervention to help HIV-infected recently incarcerated individuals link and adhere to HIV care.
    Golin CE; Knight K; Carda-Auten J; Gould M; Groves J; L White B; Bradley-Bull S; Amola K; Fray N; Rosen DL; Mugavaro MJ; Pence BW; Flynn PM; Wohl D
    BMC Public Health; 2016 Sep; 16(1):935. PubMed ID: 27596559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Trial of Real-Time Electronic Adherence Monitoring With Text Message Dosing Reminders in People Starting First-Line Antiretroviral Therapy.
    Orrell C; Cohen K; Mauff K; Bangsberg DR; Maartens G; Wood R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):495-502. PubMed ID: 26218411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial.
    Cunningham WE; Weiss RE; Nakazono T; Malek MA; Shoptaw SJ; Ettner SL; Harawa NT
    JAMA Intern Med; 2018 Apr; 178(4):542-553. PubMed ID: 29532059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analyses on initiation, adherence and outcomes of antiretroviral therapy in incarcerated people.
    Fuge TG; Tsourtos G; Miller ER
    PLoS One; 2020; 15(5):e0233355. PubMed ID: 32421754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Patient Navigation on Transitions of HIV Care After Release from Prison: A Retrospective Cohort Study.
    Westergaard RP; Hochstatter KR; Andrews PN; Kahn D; Schumann CL; Winzenried AE; Sethi AK; Gangnon RE; Sosman JM
    AIDS Behav; 2019 Sep; 23(9):2549-2557. PubMed ID: 30790170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SESOTHO trial ("Switch Either near Suppression Or THOusand") - switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: protocol of a multicenter, parallel-group, open-label, randomized clinical trial in Lesotho, Southern Africa.
    Amstutz A; Nsakala BL; Vanobberghen F; Muhairwe J; Glass TR; Achieng B; Sepeka M; Tlali K; Sao L; Thin K; Klimkait T; Battegay M; Labhardt ND
    BMC Infect Dis; 2018 Feb; 18(1):76. PubMed ID: 29433430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of an mHealth Intervention to Improve Engagement in HIV Community-Based Care Among Persons Recently Released from a Correctional Facility in Washington, DC: A Pilot Study.
    Kuo I; Liu T; Patrick R; Trezza C; Bazerman L; Uhrig Castonguay BJ; Peterson J; Kurth A; Beckwith CG
    AIDS Behav; 2019 Apr; 23(4):1016-1031. PubMed ID: 30627850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of community- versus clinic-based adherence clubs on loss from care and viral suppression for antiretroviral therapy patients: Findings from a pragmatic randomized controlled trial in South Africa.
    Hanrahan CF; Schwartz SR; Mudavanhu M; West NS; Mutunga L; Keyser V; Bassett J; Van Rie A
    PLoS Med; 2019 May; 16(5):e1002808. PubMed ID: 31112543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Routine HIV Opt-Out Screening and Continuum of Care Services Following Entry into Eight Prison Reception Centers--California, 2012.
    Lucas KD; Eckert V; Behrends CN; Wheeler C; MacGowan RJ; Mohle-Boetani JC
    MMWR Morb Mortal Wkly Rep; 2016 Feb; 65(7):178-81. PubMed ID: 26914322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of release from prison and re-incarceration on the viral loads of HIV-infected individuals.
    Stephenson BL; Wohl DA; Golin CE; Tien HC; Stewart P; Kaplan AH
    Public Health Rep; 2005; 120(1):84-8. PubMed ID: 15736336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
    Fox MP; Pascoe S; Huber AN; Murphy J; Phokojoe M; Gorgens M; Rosen S; Wilson D; Pillay Y; Fraser-Hurt N
    PLoS Med; 2019 Jul; 16(7):e1002874. PubMed ID: 31335865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health status, sexual and drug risk, and psychosocial factors relevant to postrelease planning for HIV+ prisoners.
    Feaster DJ; Reznick OG; Zack B; McCartney K; Gregorich SE; Brincks AM
    J Correct Health Care; 2013 Oct; 19(4):278-92. PubMed ID: 24078623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
    White BL; Golin CE; Grodensky CA; Kiziah CN; Richardson A; Hudgens MG; Wohl DA; Kaplan AH
    AIDS Behav; 2015 Jan; 19(1):128-36. PubMed ID: 25055766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 2 Integrated Interventions on Alcohol Abstinence and Viral Suppression Among Vietnamese Adults With Hazardous Alcohol Use and HIV: A Randomized Clinical Trial.
    Go VF; Hutton HE; Ha TV; Chander G; Latkin CA; Mai NVT; Quynh BX; Nguyen V; Sripaipan T; Lancaster KE; Blackburn N; Hershow RB; Dowdy DW; Frangakis C
    JAMA Netw Open; 2020 Sep; 3(9):e2017115. PubMed ID: 32945875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accessing antiretroviral therapy following release from prison.
    Baillargeon J; Giordano TP; Rich JD; Wu ZH; Wells K; Pollock BH; Paar DP
    JAMA; 2009 Feb; 301(8):848-57. PubMed ID: 19244192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.